Functional identification of activity‐regulated, high‐affinity glutamine transport in hippocampal neurons inhibited by riluzole

Glutamine (Gln) is considered the preferred precursor for the neurotransmitter pool of glutamate (Glu), the major excitatory transmitter in the mammalian CNS. Here, an activity‐regulated, high‐affinity Gln transport system is described in developing and mature neuron‐enriched hippocampal cultures th...

Full description

Saved in:
Bibliographic Details
Published inJournal of neurochemistry Vol. 142; no. 1; pp. 29 - 40
Main Author Erickson, Jeffrey D.
Format Journal Article
LanguageEnglish
Published England Blackwell Publishing Ltd 01.07.2017
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Glutamine (Gln) is considered the preferred precursor for the neurotransmitter pool of glutamate (Glu), the major excitatory transmitter in the mammalian CNS. Here, an activity‐regulated, high‐affinity Gln transport system is described in developing and mature neuron‐enriched hippocampal cultures that is potently inhibited by riluzole (IC50 1.3 ± 0.5 μM), an anti‐glutamatergic drug, and is blocked by low concentrations of 2‐(methylamino)isobutyrate (MeAIB), a system A transport inhibitor. K+‐stimulated MeAIB transport displays an affinity (Km) for MeAIB of 37 ± 1.2 μM, saturates at ~ 200 μM, is dependent on extracellular Ca2+, and is blocked by inhibition of voltage‐gated Ca2+ channels. Spontaneous MeAIB transport is also dependent on extracellullar Ca2+ and voltage‐gated calcium channels, but is also blocked by the Na+ channel blocker tetrodotoxin, by Glu receptor antagonists, and by GABA indicating its dependence on intact neural circuits driven by endogenous glutamatergic activity. The transport of MeAIB itself does not rely on Ca2+, but on Na+ ions, and is pH sensitive. Activity‐regulated, riluzole‐sensitive spontaneous and K+‐stimulated transport is minimal at 7–8 days in vitro, coordinately induced during the next 2 weeks and is maximally expressed by days in vitro > 20; the known period for maturation of the Glu/Gln cycle and regulated pre‐synaptic Glu release. Competition analyses with various amino acids indicate that Gln is the most likely physiological substrate. Activity‐regulated Gln/MeAIB transport is not observed in astrocytes. The functional identification of activity‐regulated, high‐affinity, riluzole‐sensitive Gln/MeAIB transport in hippocampal neurons may have important ramifications in the neurobiology of activity‐stimulated pre‐synaptic Glu release, the Glu/Gln cycle between astrocytes and neurons, and neuronal Glu‐induced excitotoxicity. Cover Image for this issue: doi: 10.1111/jnc.13805. This report describes a Ca2+‐regulated ‘system A’ glutamine transport system in hippocampal neuron‐enriched primary cultures that is dependent on neural activity in mature synapses, potently inhibited by riluzole (a blocker of synaptic glutamate release), and that is up‐regulated during the critical postnatal period of functional maturation of the glutamate/glutamine cycle between astrocytes and neurons and synaptic glutamate release. The novel high‐affinity system A transporter described here may have physiological and pathological implications in understanding the neurobiology of excitotoxic synaptic glutamate release in acute and chronic neurodegenerative diseases. Cover Image for this issue: doi: 10.1111/jnc.13805.
AbstractList Abstract Glutamine (Gln) is considered the preferred precursor for the neurotransmitter pool of glutamate (Glu), the major excitatory transmitter in the mammalian CNS . Here, an activity‐regulated, high‐affinity Gln transport system is described in developing and mature neuron‐enriched hippocampal cultures that is potently inhibited by riluzole ( IC 50 1.3 ± 0.5 μM), an anti‐glutamatergic drug, and is blocked by low concentrations of 2‐(methylamino)isobutyrate (Me AIB ), a system A transport inhibitor. K + ‐stimulated Me AIB transport displays an affinity ( K m ) for Me AIB of 37 ± 1.2 μM, saturates at ~ 200 μM, is dependent on extracellular Ca 2+ , and is blocked by inhibition of voltage‐gated Ca 2+ channels. Spontaneous Me AIB transport is also dependent on extracellullar Ca 2+ and voltage‐gated calcium channels, but is also blocked by the Na + channel blocker tetrodotoxin, by Glu receptor antagonists, and by GABA indicating its dependence on intact neural circuits driven by endogenous glutamatergic activity. The transport of Me AIB itself does not rely on Ca 2+ , but on Na + ions, and is pH sensitive. Activity‐regulated, riluzole‐sensitive spontaneous and K + ‐stimulated transport is minimal at 7–8 days in vitro , coordinately induced during the next 2 weeks and is maximally expressed by days in vitro > 20; the known period for maturation of the Glu/Gln cycle and regulated pre‐synaptic Glu release. Competition analyses with various amino acids indicate that Gln is the most likely physiological substrate. Activity‐regulated Gln/Me AIB transport is not observed in astrocytes. The functional identification of activity‐regulated, high‐affinity, riluzole‐sensitive Gln/Me AIB transport in hippocampal neurons may have important ramifications in the neurobiology of activity‐stimulated pre‐synaptic Glu release, the Glu/Gln cycle between astrocytes and neurons, and neuronal Glu‐induced excitotoxicity. image Cover Image for this issue: doi: 10.1111/jnc.13805 .
Glutamine (Gln) is considered the preferred precursor for the neurotransmitter pool of glutamate (Glu), the major excitatory transmitter in the mammalian CNS. Here, an activity-regulated, high-affinity Gln transport system is described in developing and mature neuron-enriched hippocampal cultures that is potently inhibited by riluzole (IC50 1.3 ± 0.5 μM), an anti-glutamatergic drug, and is blocked by low concentrations of 2-(methylamino)isobutyrate (MeAIB), a system A transport inhibitor. K+ -stimulated MeAIB transport displays an affinity (Km ) for MeAIB of 37 ± 1.2 μM, saturates at ~ 200 μM, is dependent on extracellular Ca2+ , and is blocked by inhibition of voltage-gated Ca2+ channels. Spontaneous MeAIB transport is also dependent on extracellullar Ca2+ and voltage-gated calcium channels, but is also blocked by the Na+ channel blocker tetrodotoxin, by Glu receptor antagonists, and by GABA indicating its dependence on intact neural circuits driven by endogenous glutamatergic activity. The transport of MeAIB itself does not rely on Ca2+ , but on Na+ ions, and is pH sensitive. Activity-regulated, riluzole-sensitive spontaneous and K+ -stimulated transport is minimal at 7-8 days in vitro, coordinately induced during the next 2 weeks and is maximally expressed by days in vitro > 20; the known period for maturation of the Glu/Gln cycle and regulated pre-synaptic Glu release. Competition analyses with various amino acids indicate that Gln is the most likely physiological substrate. Activity-regulated Gln/MeAIB transport is not observed in astrocytes. The functional identification of activity-regulated, high-affinity, riluzole-sensitive Gln/MeAIB transport in hippocampal neurons may have important ramifications in the neurobiology of activity-stimulated pre-synaptic Glu release, the Glu/Gln cycle between astrocytes and neurons, and neuronal Glu-induced excitotoxicity. Cover Image for this issue: doi: 10.1111/jnc.13805.
Glutamine (Gln) is considered the preferred precursor for the neurotransmitter pool of glutamate (Glu), the major excitatory transmitter in the mammalian CNS. Here, an activity-regulated, high-affinity Gln transport system is described in developing and mature neuron-enriched hippocampal cultures that is potently inhibited by riluzole (IC 1.3 ± 0.5 μM), an anti-glutamatergic drug, and is blocked by low concentrations of 2-(methylamino)isobutyrate (MeAIB), a system A transport inhibitor. K -stimulated MeAIB transport displays an affinity (K ) for MeAIB of 37 ± 1.2 μM, saturates at ~ 200 μM, is dependent on extracellular Ca , and is blocked by inhibition of voltage-gated Ca channels. Spontaneous MeAIB transport is also dependent on extracellullar Ca and voltage-gated calcium channels, but is also blocked by the Na channel blocker tetrodotoxin, by Glu receptor antagonists, and by GABA indicating its dependence on intact neural circuits driven by endogenous glutamatergic activity. The transport of MeAIB itself does not rely on Ca , but on Na ions, and is pH sensitive. Activity-regulated, riluzole-sensitive spontaneous and K -stimulated transport is minimal at 7-8 days in vitro, coordinately induced during the next 2 weeks and is maximally expressed by days in vitro > 20; the known period for maturation of the Glu/Gln cycle and regulated pre-synaptic Glu release. Competition analyses with various amino acids indicate that Gln is the most likely physiological substrate. Activity-regulated Gln/MeAIB transport is not observed in astrocytes. The functional identification of activity-regulated, high-affinity, riluzole-sensitive Gln/MeAIB transport in hippocampal neurons may have important ramifications in the neurobiology of activity-stimulated pre-synaptic Glu release, the Glu/Gln cycle between astrocytes and neurons, and neuronal Glu-induced excitotoxicity. Cover Image for this issue: doi: 10.1111/jnc.13805.
Glutamine (Gln) is considered the preferred precursor for the neurotransmitter pool of glutamate (Glu), the major excitatory transmitter in the mammalian CNS. Here, an activity-regulated, high-affinity Gln transport system is described in developing and mature neuron-enriched hippocampal cultures that is potently inhibited by riluzole (IC 50 1.3 +/− 0.5µM), an anti-glutamatergic drug, and is blocked by low concentrations of 2-(methylamino)isobutyrate (MeAIB), a system A transport inhibitor. K + -stimulated MeAIB transport displays an affinity ( K m ) for MeAIB of 37 +/− 1.2 µM, saturates at ~200 µM, is dependent on extracellular Ca 2+ , and is blocked by inhibition of voltage gated Ca 2+ -channels (VGCCs). Spontaneous MeAIB transport is also dependent on extracellullar Ca 2+ and VGCCs, but is also blocked by the Na + channel blocker tetrodotoxin, by Glu receptor antagonists, and by GABA indicating its dependence on intact neural circuits driven by endogenous glutamatergic activity. The transport of MeAIB itself does not rely on Ca 2+ , but on Na + ions, and is pH-sensitive. Activity-regulated, riluzole-sensitive spontaneous and K + -stimulated transport is minimal at 7–8 days in vitro (DIV), coordinantly induced during the next two weeks, and is maximally expressed by DIV>20; the known period for maturation of the Glu/Gln cycle and regulated presynaptic Glu release. Competition analyses with various amino acids indicate that Gln is the most likely physiological substrate. Activity-regulated Gln/MeAIB transport is not observed in astrocytes. The functional identification of activity-regulated, high-affinity, riluzole-sensitive Gln/MeAIB transport in hippocampal neurons may have important ramifications in the neurobiology of activity stimulated presynaptic Glu release, the Glu/Gln cycle between astrocytes and neurons, and neuronal Glu-induced excitotoxicity. This report describes a Ca 2+ -regulated ‘system A’ glutamine transport system in hippocampal neuron-enriched primary cultures that is dependent on neural activity in mature synapses, potently inhibited by riluzole (a blocker of synaptic glutamate release), and that is up-regulated during the critical postnatal period of functional maturation of the glutamate/glutamine cycle between astrocytes and neurons and synaptic glutamate release. The novel high-affinity system A transporter described here may have physiological and pathological implications in understanding the neurobiology of excitotoxic synaptic glutamate release in acute and chronic neurodegenerative diseases.
Glutamine (Gln) is considered the preferred precursor for the neurotransmitter pool of glutamate (Glu), the major excitatory transmitter in the mammalian CNS. Here, an activity‐regulated, high‐affinity Gln transport system is described in developing and mature neuron‐enriched hippocampal cultures that is potently inhibited by riluzole (IC50 1.3 ± 0.5 μM), an anti‐glutamatergic drug, and is blocked by low concentrations of 2‐(methylamino)isobutyrate (MeAIB), a system A transport inhibitor. K+‐stimulated MeAIB transport displays an affinity (Km) for MeAIB of 37 ± 1.2 μM, saturates at ~ 200 μM, is dependent on extracellular Ca2+, and is blocked by inhibition of voltage‐gated Ca2+ channels. Spontaneous MeAIB transport is also dependent on extracellullar Ca2+ and voltage‐gated calcium channels, but is also blocked by the Na+ channel blocker tetrodotoxin, by Glu receptor antagonists, and by GABA indicating its dependence on intact neural circuits driven by endogenous glutamatergic activity. The transport of MeAIB itself does not rely on Ca2+, but on Na+ ions, and is pH sensitive. Activity‐regulated, riluzole‐sensitive spontaneous and K+‐stimulated transport is minimal at 7–8 days in vitro, coordinately induced during the next 2 weeks and is maximally expressed by days in vitro > 20; the known period for maturation of the Glu/Gln cycle and regulated pre‐synaptic Glu release. Competition analyses with various amino acids indicate that Gln is the most likely physiological substrate. Activity‐regulated Gln/MeAIB transport is not observed in astrocytes. The functional identification of activity‐regulated, high‐affinity, riluzole‐sensitive Gln/MeAIB transport in hippocampal neurons may have important ramifications in the neurobiology of activity‐stimulated pre‐synaptic Glu release, the Glu/Gln cycle between astrocytes and neurons, and neuronal Glu‐induced excitotoxicity. Cover Image for this issue: doi: 10.1111/jnc.13805. This report describes a Ca2+‐regulated ‘system A’ glutamine transport system in hippocampal neuron‐enriched primary cultures that is dependent on neural activity in mature synapses, potently inhibited by riluzole (a blocker of synaptic glutamate release), and that is up‐regulated during the critical postnatal period of functional maturation of the glutamate/glutamine cycle between astrocytes and neurons and synaptic glutamate release. The novel high‐affinity system A transporter described here may have physiological and pathological implications in understanding the neurobiology of excitotoxic synaptic glutamate release in acute and chronic neurodegenerative diseases. Cover Image for this issue: doi: 10.1111/jnc.13805.
Glutamine (Gln) is considered the preferred precursor for the neurotransmitter pool of glutamate (Glu), the major excitatory transmitter in the mammalian CNS. Here, an activity-regulated, high-affinity Gln transport system is described in developing and mature neuron-enriched hippocampal cultures that is potently inhibited by riluzole (IC50 1.3 ± 0.5 µM), an anti-glutamatergic drug, and is blocked by low concentrations of 2-(methylamino)isobutyrate (MeAIB), a system A transport inhibitor. K+-stimulated MeAIB transport displays an affinity (Km) for MeAIB of 37 ± 1.2 µM, saturates at ~ 200 µM, is dependent on extracellular Ca2+, and is blocked by inhibition of voltage-gated Ca2+ channels. Spontaneous MeAIB transport is also dependent on extracellullar Ca2+ and voltage-gated calcium channels, but is also blocked by the Na+ channel blocker tetrodotoxin, by Glu receptor antagonists, and by GABA indicating its dependence on intact neural circuits driven by endogenous glutamatergic activity. The transport of MeAIB itself does not rely on Ca2+, but on Na+ ions, and is pH sensitive. Activity-regulated, riluzole-sensitive spontaneous and K+-stimulated transport is minimal at 7-8 days in vitro, coordinately induced during the next 2 weeks and is maximally expressed by days in vitro > 20; the known period for maturation of the Glu/Gln cycle and regulated pre-synaptic Glu release. Competition analyses with various amino acids indicate that Gln is the most likely physiological substrate. Activity-regulated Gln/MeAIB transport is not observed in astrocytes. The functional identification of activity-regulated, high-affinity, riluzole-sensitive Gln/MeAIB transport in hippocampal neurons may have important ramifications in the neurobiology of activity-stimulated pre-synaptic Glu release, the Glu/Gln cycle between astrocytes and neurons, and neuronal Glu-induced excitotoxicity. Cover Image for this issue: doi: 10.1111/jnc.13805.
Author Erickson, Jeffrey D.
Author_xml – sequence: 1
  givenname: Jeffrey D.
  orcidid: 0000-0003-4598-9898
  surname: Erickson
  fullname: Erickson, Jeffrey D.
  email: jerick@lsuhsc.edu
  organization: Lousiania State University Health New Orleans
BackLink https://www.ncbi.nlm.nih.gov/pubmed/28423185$$D View this record in MEDLINE/PubMed
BookMark eNp1kd1qFDEYhoNU7LZ64A3IgCcKTptkkmzmRJDF-kPREz0O32SS3SyZZExmKtujgjfgNXolZt1aVDAnge99ePiS9wQdhRgMQo8JPiPlnG-DPiMMM3EPLQhbkpoR3h6hBcaU1g1m9Bid5LzFmAgmyAN0TCWjDZF8gb5dzEFPLgbwletNmJx1GvaDKtoKSnTlpt2Pm-_JrGcPk-lfVBu33pQJWOtCCau1nycYXDDVlCDkMaapcqFg4xg1DGNRBzOnGHIZb1zniqXqdlVyfr6O3jxE9y34bB7d3qfo88XrT6u39eXHN-9Wry5rzVgjass73WC55KbhjWS2lxK3sgPdMaopBbOkwBlwaQohlkIKLTvDuejBgjXQnKKXB-84d4PpdXltAq_G5AZIOxXBqb-T4DZqHa8U5y3jQhbBs1tBil9mkyc1uKyN9xBMnLMisiVYtpLu0af_oNs4p_LLhWoJ4UTIlhbq-YHSKeacjL1bhmC1r1aVatWvagv75M_t78jfXRbg_AB8dd7s_m9S7z-sDsqfseW15Q
CitedBy_id crossref_primary_10_1016_j_aquaculture_2020_735257
crossref_primary_10_1016_j_neuint_2018_12_006
crossref_primary_10_1016_j_neuropharm_2021_108719
crossref_primary_10_3390_ijms22031167
crossref_primary_10_1007_s12035_024_03966_3
crossref_primary_10_1016_j_neuropharm_2022_109349
crossref_primary_10_1152_ajplung_00461_2020
crossref_primary_10_1007_s11064_020_02974_8
crossref_primary_10_1016_j_mce_2018_07_008
crossref_primary_10_1016_j_crphys_2023_100109
crossref_primary_10_3390_ijms24043841
crossref_primary_10_1007_s12035_020_01912_7
crossref_primary_10_1002_1873_3468_13584
crossref_primary_10_1016_j_ecoenv_2022_113783
crossref_primary_10_1111_jnc_15224
crossref_primary_10_1111_jnc_15238
crossref_primary_10_1007_s12035_018_1433_x
crossref_primary_10_3390_ph15101297
Cites_doi 10.1523/JNEUROSCI.1466-13.2013
10.1523/JNEUROSCI.20-04-01342.2000
10.1007/s00424-003-1117-9
10.1111/j.1460-9568.2010.07378.x
10.1016/j.ejmech.2016.11.053
10.1002/jnr.490350513
10.1074/jbc.M806407200
10.1038/nrn3379
10.1111/j.1460-9568.2007.05967.x
10.1074/jbc.M806470200
10.1016/S0079-6123(07)63041-6
10.1006/exnr.1997.6554
10.2741/2067
10.1089/neu.2015.4373
10.1101/lm.54603
10.1126/science.7569903
10.1074/jbc.M110.162404
10.1016/0006-8993(89)90045-0
10.1016/j.neuroscience.2004.01.019
10.1083/jcb.200201070
10.1016/j.brainres.2010.11.064
10.1007/978-3-319-45096-4_8
10.1007/s10072-011-0828-5
10.1016/0304-3940(92)90108-J
10.1212/WNL.59.9_suppl_5.S3
10.1016/S0896-6273(00)81203-9
10.1016/0014-2999(93)90037-I
10.1016/j.mam.2012.07.012
10.1523/JNEUROSCI.23-23-08212.2003
10.1111/j.1748-1716.2006.01552.x
10.1016/0306-4522(80)90130-X
10.1111/j.1471-4159.1984.tb05396.x
10.1016/0006-8993(79)90307-X
10.1023/A:1015255312948
10.1046/j.1471-4159.2003.01713.x
10.1016/j.neuron.2013.12.026
10.1038/mp.2016.33
10.1016/S0304-3940(99)00810-1
10.1016/0304-3940(92)90597-Z
10.1042/bj2990321
10.1179/016164107X159225
10.1016/S0304-3940(00)01536-6
10.1074/jbc.M608548200
10.1523/JNEUROSCI.1198-07.2007
10.1111/j.1527-3458.1997.tb00318.x
10.1177/088307389701200802
10.1152/physrev.1990.70.1.43
10.1212/WNL.47.6_Suppl_4.233S
10.1016/j.eplepsyres.2013.08.007
10.1016/j.neuroscience.2009.09.015
10.1097/00001756-200507130-00011
10.1523/JNEUROSCI.5221-04.2005
10.1007/BF00370302
10.1007/s13311-014-0305-y
10.1038/sj.jcbfm.9600490
10.1046/j.1471-4159.2001.00074.x
10.1523/JNEUROSCI.3003-04.2005
10.1523/JNEUROSCI.09-11-03720.1989
10.1093/cercor/bhn151
10.1523/JNEUROSCI.23-30-09697.2003
10.1073/pnas.121183498
10.1046/j.1460-9568.1999.00540.x
10.1046/j.1471-4159.2001.00156.x
10.1016/j.biopha.2016.12.067
10.1016/j.jmb.2014.10.016
10.1097/00001756-200207020-00019
10.1021/acsami.6b01776
10.1007/PL00005241
10.1074/jbc.M212718200
10.1002/jnr.23561
10.1074/jbc.M200374200
10.1016/j.neuroscience.2005.08.083
10.1016/j.neuron.2009.06.010
10.1016/S0301-0082(96)00049-4
10.1097/00001756-199806220-00037
10.1016/j.neuint.2005.11.016
10.1152/jn.00464.2004
10.1111/jnc.13230
10.1111/j.1471-4159.2012.07684.x
10.1074/jbc.M110942200
10.3389/fendo.2013.00059
10.1523/JNEUROSCI.0106-09.2010
10.1152/jn.00665.2001
10.1523/JNEUROSCI.23-05-01563.2003
ContentType Journal Article
Copyright 2017 International Society for Neurochemistry
2017 International Society for Neurochemistry.
Copyright © 2017 International Society for Neurochemistry
Copyright_xml – notice: 2017 International Society for Neurochemistry
– notice: 2017 International Society for Neurochemistry.
– notice: Copyright © 2017 International Society for Neurochemistry
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7QR
7TK
7U7
7U9
8FD
C1K
FR3
H94
P64
7X8
5PM
DOI 10.1111/jnc.14046
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
Chemoreception Abstracts
Neurosciences Abstracts
Toxicology Abstracts
Virology and AIDS Abstracts
Technology Research Database
Environmental Sciences and Pollution Management
Engineering Research Database
AIDS and Cancer Research Abstracts
Biotechnology and BioEngineering Abstracts
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
Virology and AIDS Abstracts
Technology Research Database
Toxicology Abstracts
AIDS and Cancer Research Abstracts
Chemoreception Abstracts
Engineering Research Database
Neurosciences Abstracts
Biotechnology and BioEngineering Abstracts
Environmental Sciences and Pollution Management
MEDLINE - Academic
DatabaseTitleList CrossRef
MEDLINE - Academic
MEDLINE


Virology and AIDS Abstracts
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Anatomy & Physiology
Chemistry
EISSN 1471-4159
EndPage 40
ExternalDocumentID 10_1111_jnc_14046
28423185
JNC14046
Genre article
Research Support, Non-U.S. Gov't
Journal Article
Research Support, N.I.H., Extramural
GrantInformation_xml – fundername: LSUHSC Research Enhancement Fund
  funderid: 5497500049
– fundername: National Institute of Mental Health
  funderid: R21 14975051
– fundername: NIMH NIH HHS
  grantid: R21 MH101612
GroupedDBID ---
-~X
.3N
.55
.GA
.GJ
.Y3
05W
0R~
10A
1OB
1OC
24P
29L
2WC
31~
33P
36B
3SF
4.4
41~
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52U
52V
52W
52X
53G
5GY
5HH
5LA
5RE
5VS
66C
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A01
A03
AAESR
AAEVG
AAHHS
AANLZ
AAONW
AASGY
AAXRX
AAYJJ
AAZKR
ABCQN
ABCUV
ABEML
ABIVO
ABLJU
ABPVW
ABQWH
ABXGK
ACAHQ
ACBWZ
ACCFJ
ACCZN
ACFBH
ACGFO
ACGFS
ACGOD
ACGOF
ACIWK
ACMXC
ACNCT
ACPOU
ACPRK
ACSCC
ACXBN
ACXQS
ADBBV
ADBTR
ADEOM
ADIZJ
ADKYN
ADMGS
ADOZA
ADXAS
ADZMN
AEEZP
AEGXH
AEIGN
AEIMD
AENEX
AEQDE
AEUQT
AEUYR
AFBPY
AFEBI
AFFPM
AFGKR
AFPWT
AFRAH
AFZJQ
AHBTC
AHEFC
AI.
AIACR
AIAGR
AITYG
AIURR
AIWBW
AJBDE
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
AMBMR
AMYDB
ASPBG
ATUGU
AVWKF
AZBYB
AZFZN
AZVAB
BAFTC
BAWUL
BDRZF
BFHJK
BHBCM
BMXJE
BROTX
BRXPI
BY8
C45
CAG
COF
CS3
D-6
D-7
D-E
D-F
DC6
DCZOG
DIK
DPXWK
DR2
DRFUL
DRMAN
DRSTM
DU5
E3Z
EBS
EJD
EMOBN
ESX
EX3
F00
F01
F04
F5P
FEDTE
FIJ
FUBAC
FZ0
G-S
G.N
GAKWD
GODZA
GX1
H.X
HF~
HGLYW
HH5
HVGLF
HZI
HZ~
IH2
IHE
IPNFZ
IX1
J0M
K48
KBYEO
LATKE
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
MEWTI
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MVM
MXFUL
MXMAN
MXSTM
N04
N05
N9A
NF~
O66
O9-
OIG
OK1
OVD
P2P
P2W
P2X
P2Z
P4B
P4D
PALCI
PQQKQ
Q.N
Q11
QB0
R.K
RIWAO
RJQFR
ROL
RX1
SAMSI
SUPJJ
TEORI
TWZ
UB1
V8K
VH1
W8V
W99
WBKPD
WIH
WIJ
WIK
WIN
WNSPC
WOHZO
WOW
WQJ
WRC
WUP
WXI
WXSBR
WYISQ
X7M
XG1
XJT
YFH
YNH
YOC
YUY
ZGI
ZXP
ZZTAW
~IA
~KM
~WT
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7QR
7TK
7U7
7U9
8FD
C1K
FR3
H94
P64
7X8
5PM
ID FETCH-LOGICAL-c4436-f5bc30875e35384fd88098bacb42c22ae72a54a58e5e367686c8be556dafafea3
IEDL.DBID DR2
ISSN 0022-3042
IngestDate Tue Sep 17 21:16:32 EDT 2024
Thu Jul 25 09:33:18 EDT 2024
Thu Oct 10 22:13:02 EDT 2024
Fri Aug 23 02:03:41 EDT 2024
Tue Aug 27 13:44:50 EDT 2024
Sat Aug 24 00:55:58 EDT 2024
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords neurotransmitter cycling
neuronal glutamine transporter
glutamate/glutamine cycle
excitotoxicity
activity-dependent regulation
neuroprotection
Language English
License 2017 International Society for Neurochemistry.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c4436-f5bc30875e35384fd88098bacb42c22ae72a54a58e5e367686c8be556dafafea3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
DR. JEFFREY D. ERICKSON (Orcid ID : 0000-0003-4598-9898)
ORCID 0000-0003-4598-9898
OpenAccessLink https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/jnc.14046
PMID 28423185
PQID 1911516892
PQPubID 31528
PageCount 12
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_5594568
proquest_miscellaneous_1891089828
proquest_journals_1911516892
crossref_primary_10_1111_jnc_14046
pubmed_primary_28423185
wiley_primary_10_1111_jnc_14046_JNC14046
PublicationCentury 2000
PublicationDate July 2017
PublicationDateYYYYMMDD 2017-07-01
PublicationDate_xml – month: 07
  year: 2017
  text: July 2017
PublicationDecade 2010
PublicationPlace England
PublicationPlace_xml – name: England
– name: New York
PublicationTitle Journal of neurochemistry
PublicationTitleAlternate J Neurochem
PublicationYear 2017
Publisher Blackwell Publishing Ltd
Publisher_xml – name: Blackwell Publishing Ltd
References 1994; 299
2013; 29
2002; 59
2012; 121
2013; 4
2004; 125
2002; 157
2002; 13
2002; 277
2000; 294
2015; 427
1999; 288
1998; 358
2006; 137
2003; 278
1997; 3
2004; 447
2003; 10
2016; 34
2005; 25
1997; 147
1993; 35
1997; 51
2013; 14
2015; 135
2002; 88
1997; 12
2016; 87
1999; 11
1993; 250
2009; 284
2009; 164
2009; 19
2003; 85
2010; 30
2011; 286
2007; 26
2007; 27
2001; 98
2011; 1371
2015; 12
1979; 168
2010; 32
2009; 63
1992; 140
2007; 282
2015; 93
2000; 26
1984; 43
1992; 147
2007; 163
2013; 107
1989; 9
2000; 20
1994; 45
2002; 3
2016; 126
2007; 12
2012; 33
1991; 419
2016; 13
2014; 81
2004; 92
2013; 33
1997; 282
2013; 34
1989; 483
2006; 48
1980; 5
2006; 187
1995; 269
2016
1999; 276
1996; 47
2005; 16
2016; 8
1990; 70
1998; 9
2003; 23
2001; 76
2016; 22
e_1_2_8_28_1
e_1_2_8_26_1
e_1_2_8_49_1
e_1_2_8_68_1
Kanthasamy A. G. (e_1_2_8_47_1) 1999; 288
e_1_2_8_3_1
Herbert T. (e_1_2_8_37_1) 1994; 45
e_1_2_8_81_1
e_1_2_8_5_1
e_1_2_8_7_1
e_1_2_8_9_1
e_1_2_8_20_1
e_1_2_8_43_1
e_1_2_8_66_1
e_1_2_8_89_1
e_1_2_8_22_1
e_1_2_8_45_1
e_1_2_8_64_1
e_1_2_8_87_1
e_1_2_8_62_1
e_1_2_8_85_1
e_1_2_8_41_1
e_1_2_8_60_1
e_1_2_8_83_1
e_1_2_8_17_1
e_1_2_8_19_1
e_1_2_8_13_1
e_1_2_8_36_1
e_1_2_8_59_1
e_1_2_8_15_1
e_1_2_8_38_1
e_1_2_8_57_1
Gois S. (e_1_2_8_23_1) 2005; 25
e_1_2_8_70_1
e_1_2_8_32_1
e_1_2_8_55_1
e_1_2_8_78_1
e_1_2_8_11_1
e_1_2_8_34_1
e_1_2_8_53_1
e_1_2_8_76_1
e_1_2_8_51_1
e_1_2_8_74_1
e_1_2_8_30_1
e_1_2_8_72_1
e_1_2_8_25_1
e_1_2_8_46_1
e_1_2_8_27_1
e_1_2_8_48_1
e_1_2_8_69_1
e_1_2_8_2_1
e_1_2_8_80_1
e_1_2_8_4_1
e_1_2_8_6_1
e_1_2_8_8_1
e_1_2_8_21_1
Deken S. L. (e_1_2_8_24_1) 2003; 23
e_1_2_8_42_1
e_1_2_8_67_1
e_1_2_8_88_1
e_1_2_8_44_1
e_1_2_8_65_1
e_1_2_8_86_1
e_1_2_8_63_1
e_1_2_8_84_1
e_1_2_8_40_1
e_1_2_8_61_1
e_1_2_8_82_1
e_1_2_8_18_1
e_1_2_8_39_1
e_1_2_8_14_1
e_1_2_8_35_1
e_1_2_8_16_1
e_1_2_8_58_1
e_1_2_8_79_1
Song J. H. (e_1_2_8_77_1) 1997; 282
e_1_2_8_10_1
e_1_2_8_31_1
e_1_2_8_56_1
e_1_2_8_12_1
Erickson J. D. (e_1_2_8_29_1) 2016
e_1_2_8_33_1
e_1_2_8_54_1
e_1_2_8_75_1
e_1_2_8_52_1
e_1_2_8_73_1
e_1_2_8_50_1
e_1_2_8_71_1
References_xml – volume: 26
  start-page: 3437
  year: 2007
  end-page: 3448
  article-title: Regulated recycling and plasma membrane recruitment of the high‐affinity choline transporter
  publication-title: Eur. J. Neurosci.
– volume: 447
  start-page: 784
  year: 2004
  end-page: 795
  article-title: Sodium‐coupled neutral amino acid (System N/A) transporters of the SLC38 gene family
  publication-title: Pflugers Arch.
– volume: 147
  start-page: 209
  year: 1992
  end-page: 212
  article-title: Riluzole inhibits the release of glutamate in the caudate nucleus of the cat
  publication-title: Neurosci. Lett.
– volume: 13
  start-page: 1167
  year: 2002
  end-page: 1170
  article-title: Lamotrigine derivatives and riluzole inhibit INa2P in cortical neurons
  publication-title: NeuroReport
– volume: 107
  start-page: 20
  year: 2013
  end-page: 36
  article-title: Electrographic seizures are significantly reduced by in vivo inhibition of neuronal uptake of extracellular glutamine in rat hippocampus
  publication-title: Epilepsy Res.
– volume: 93
  start-page: 1031
  year: 2015
  end-page: 1044
  article-title: Maintaining the presynaptic glutamate supply for excitatory neurotransmission
  publication-title: J. Neurosci. Res.
– volume: 3
  start-page: 51
  year: 2002
  end-page: 56
  article-title: Excited to death: different ways to lose your neurons
  publication-title: Biogerontology
– volume: 88
  start-page: 2302
  year: 2002
  end-page: 2310
  article-title: Block of glutamate‐glutamine cycle between astrocytes and neurons inhibits epileptiform activity in hippocampus
  publication-title: J. Neurophysiol.
– volume: 11
  start-page: 1349
  year: 1999
  end-page: 1361
  article-title: Unexpected localization of the Na /Cl dependent‐like orphan transporter, Rxt1, on synaptic vesicles in the rat central nervous system
  publication-title: Eur. J. Neurosci.
– volume: 187
  start-page: 273
  year: 2006
  end-page: 283
  article-title: The role of the neutral amino acid transporter SNAT2 in cell volume regulation
  publication-title: Acta Physiol. (Oxf)
– volume: 358
  start-page: 181
  year: 1998
  end-page: 190
  article-title: Riluzole, a glutamate release inhibitor, and motor behavior.
  publication-title: Arch. Pharm.
– volume: 9
  start-page: 2109
  year: 1998
  end-page: 2114
  article-title: Excitotoxicity and repair of cochlear synapses after noise‐trauma induced hearing loss
  publication-title: NeuroReport
– volume: 121
  start-page: 184
  year: 2012
  end-page: 196
  article-title: Synaptic vesicles are capable of synthesizing the VGLUT substrate glutamate from α‐ketoglutarate for vesicular loading
  publication-title: J. Neurochem.
– volume: 25
  start-page: 7121
  year: 2005
  end-page: 7133
  article-title: Homeostatic scaling of vesicular glutamate and GABA transporter expression in rat neocortical circuits
  publication-title: J. Neurosci.
– volume: 9
  start-page: 3720
  year: 1989
  end-page: 3727
  article-title: Riluzole, a novel antiglutamate, prevents memory loss and hippocampal neuronal damage in ischemic gerbils
  publication-title: J. Neurosci.
– volume: 23
  start-page: 9697
  year: 2003
  end-page: 9709
  article-title: Vesicular localization and activity‐dependent trafficking of presynaptic choline transporters
  publication-title: J. Neurosci.
– volume: 10
  start-page: 86
  year: 2003
  end-page: 98
  article-title: BDNF and activity‐dependent synaptic modulation
  publication-title: Learn. Mem.
– volume: 483
  start-page: 143
  year: 1989
  end-page: 148
  article-title: Phenytoin protects against ischemia‐produced neuronal cell death
  publication-title: Brain Res.
– volume: 59
  start-page: S3
  year: 2002
  end-page: S6
  article-title: Seizure‐induced neuronal injury: animal data
  publication-title: Neurology
– volume: 33
  start-page: 223
  year: 2012
  end-page: 237
  article-title: The role of glutamate in neuronal ischemic injury: the role of spark in fire
  publication-title: Neurol. Sci.
– volume: 137
  start-page: 241
  year: 2006
  end-page: 251
  article-title: Alpha‐linolenic acid and riluzole treatment confer cerebral protection and improve survival after focal brain ischemia
  publication-title: Neuroscience
– volume: 43
  start-page: 1369
  year: 1984
  end-page: 1374
  article-title: Elevation of the extracellular concentrations of glutamate and aspartate in rat hippocampus during transient cerebral ischemia monitored by intracerebral microdialysis
  publication-title: J. Neurochem.
– volume: 276
  start-page: 127
  year: 1999
  end-page: 130
  article-title: Effects of anticonvulsants on veratridine‐ and KCl‐evoked glutamate release from rat cortical synaptosomes
  publication-title: Neurosci. Lett.
– volume: 299
  start-page: 321
  issue: Pt 2
  year: 1994
  end-page: 334
  article-title: Regulatory and molecular aspects of mammalian amino acid transport
  publication-title: Biochem. J.
– volume: 19
  start-page: 1092
  year: 2009
  end-page: 1106
  article-title: System A transporter SNAT2 mediates replenishment of dendritic pools controlling retrograde signaling by glutamate
  publication-title: Cereb. Cortex
– volume: 92
  start-page: 2714
  year: 2004
  end-page: 2724
  article-title: Developmental changes in release properties of the CA3‐CA1 glutamate synapse in rat hippocampus
  publication-title: J. Neurophysiol.
– volume: 126
  start-page: 614
  year: 2016
  end-page: 630
  article-title: Synthesis and biological evaluation of a new class of benzothiazines as neuroprotective agents
  publication-title: Eur. J. Med. Chem.
– volume: 12
  start-page: 234
  year: 2015
  end-page: 249
  article-title: The riluzole derivative 2‐amino‐6‐trifluoromethylthio‐benzothiazole (SKA‐19), a mixed KCa2 activator and Na V blocker, is a potent novel anticonvulsant
  publication-title: Neurotherapeutics
– volume: 81
  start-page: 888
  year: 2014
  end-page: 900
  article-title: A local glutamate‐glutamine cycle sustains synaptic excitatory transmitter release
  publication-title: Neuron
– volume: 87
  start-page: 135
  year: 2016
  end-page: 144
  article-title: Riluzole ameliorates learning and memory deficits in Aβ25‐35‐induced rat model of Alzheimer's disease and is independent of cholinoceptor activation
  publication-title: Biomed. Pharmacother.
– volume: 47
  start-page: S233
  issue: 6 Suppl 4
  year: 1996
  end-page: S241
  article-title: The pharmacology and mechanism of action of riluzole
  publication-title: Neurology
– volume: 35
  start-page: 567
  year: 1993
  end-page: 576
  article-title: Optimized survival of hippocampal neurons in B27‐supplemented Neurobasal, a new serum‐free medium combination
  publication-title: J. Neurosci. Res.
– volume: 13
  start-page: 223
  year: 2016
  end-page: 257
  article-title: The glutamine transporters and their role in the glutamate/GABA‐glutamine cycle
  publication-title: Adv. Neurobiol.
– volume: 30
  start-page: 1288
  year: 2010
  end-page: 1300
  article-title: Glutamine is required for persistent epileptiform activity in the disinhibited neocortical brain slice
  publication-title: J. Neurosci.
– volume: 125
  start-page: 191
  year: 2004
  end-page: 201
  article-title: Mechanisms underlying the riluzole inhibition of glutamate release from rat cerebral cortex nerve terminals (synaptosomes)
  publication-title: Neuroscience
– volume: 85
  start-page: 503
  year: 2003
  end-page: 514
  article-title: Inhibition of glutamine transport depletes glutamate and GABA neurotransmitter pools: further evidence for metabolic compartmentation
  publication-title: J. Neurochem.
– volume: 63
  start-page: 216
  year: 2009
  end-page: 229
  article-title: Calcium dependence of exo‐ and endocytotic coupling at a glutamatergic synapse
  publication-title: Neuron
– volume: 135
  start-page: 381
  year: 2015
  end-page: 394
  article-title: Riluzole rescues glutamate alterations, cognitive deficits, and tau pathology associated with P301L tau expression
  publication-title: J. Neurochem.
– volume: 277
  start-page: 10467
  year: 2002
  end-page: 10473
  article-title: Localization and functional relevance of system A neutral amino acid transporters in cultured hippocampal neurons
  publication-title: J. Biol. Chem.
– volume: 278
  start-page: 23720
  year: 2003
  end-page: 23730
  article-title: Functional properties and cellular distribution of the system A glutamine transporter SNAT1 support specialized roles in central neurons
  publication-title: J. Biol. Chem.
– volume: 284
  start-page: 11224
  year: 2009
  end-page: 11236
  article-title: SNAT2 amino acid transporter is regulated by amino acids of the gamma‐aminobutyric acid transporter subfamily in neocortical neurons and may play no role in delivering glutamine for glutamatergic transmission
  publication-title: J. Biol. Chem.
– volume: 23
  start-page: 1563
  year: 2003
  end-page: 1568
  article-title: Plasma membrane GABA transporters reside on distinct vesicles and undergo rapid regulated recycling
  publication-title: J. Neurosci.
– volume: 164
  start-page: 998
  year: 2009
  end-page: 1008
  article-title: Functional expression of two system A glutamine transporter isoforms in rat auditory brainstem neurons
  publication-title: Neuroscience
– volume: 157
  start-page: 349
  year: 2002
  end-page: 355
  article-title: The glutamine commute: take the N line and transfer to the A
  publication-title: J. Cell Biol.
– volume: 12
  start-page: 471
  year: 1997
  end-page: 485
  article-title: Glutamate in neurologic diseases
  publication-title: J. Child Neurol.
– volume: 27
  start-page: 9192
  year: 2007
  end-page: 9200
  article-title: Excitatory synaptic transmission persists independently of the glutamate‐glutamine cycle
  publication-title: J. Neurosci.
– volume: 3
  start-page: 83
  year: 1997
  end-page: 101
  article-title: Neuroprotective profile of riluzole in models of acute neurodegenerative diseases
  publication-title: CNS Drug Rev.
– volume: 8
  start-page: 19716
  year: 2016
  end-page: 19723
  article-title: Enhancement in the neuroprotective power of riluzole against cerebral ischemia using a brain targeted drug delivery vehicle
  publication-title: ACS Appl. Mater. Interfaces.
– volume: 286
  start-page: 20500
  year: 2011
  end-page: 20511
  article-title: Identification of (SNAT7) protein as a glutamine transporter expressed in neurons
  publication-title: J. Biol. Chem.
– volume: 163
  start-page: 755
  year: 2007
  end-page: 773
  article-title: Epileptogenesis in the dentate gyrus: a critical perspective
  publication-title: Prog. Brain Res.
– volume: 419
  start-page: 603
  year: 1991
  end-page: 609
  article-title: Riluzole specifically blocks inactivated Na channels in myelinated nerve fibre
  publication-title: Pflugers Arch.
– volume: 27
  start-page: 1895
  year: 2007
  end-page: 1907
  article-title: Glutamatergic and GABAergic neurotransmitter cycling and energy metabolism in rat cerebral cortex during postnatal development
  publication-title: J. Cereb. Blood Flow Metab.
– volume: 250
  start-page: 473
  year: 1993
  end-page: 476
  article-title: The neuroprotective agent riluzole inhibits release of glutamate and aspartate from slices of hippocampal area CA1
  publication-title: Eur. J. Pharmacol.
– volume: 23
  start-page: 8212
  year: 2003
  end-page: 8220
  article-title: Brain‐derived neurotrophic factor stimulates energy metabolism in developing cortical neurons
  publication-title: J. Neurosci.
– volume: 33
  start-page: 17429
  year: 2013
  end-page: 17434
  article-title: Inducible presynaptic glutamatergic transport supports glutamatergic transmission at the calyx of Held synapse
  publication-title: J. Neurosci.
– volume: 20
  start-page: 1342
  year: 2000
  end-page: 1347
  article-title: Neuronal pyruvate carboxylation supports formation of transmitter glutamate
  publication-title: J. Neurosci.
– volume: 16
  start-page: 1087
  year: 2005
  end-page: 1090
  article-title: Neuroprotective effect of riluzole in acute noise‐induced hearing loss
  publication-title: NeuroReport
– volume: 48
  start-page: 459
  year: 2006
  end-page: 464
  article-title: The glutamine commute: lost in the tube?
  publication-title: Neurochem. Int.
– volume: 76
  start-page: 975
  year: 2001
  end-page: 989
  article-title: (13)C NMR measurement of neurotransmitter glutamate cycling, anaplerosis and TCA cycle flux in rat brain during [2‐13C]glucose infusion
  publication-title: J. Neurochem.
– year: 2016
– volume: 147
  start-page: 115
  year: 1997
  end-page: 122
  article-title: Differential inhibition by riluzole, lamotrigine, and phenytoin of sodium and calcium currents in cortical neurons: implications for neuroprotective strategies
  publication-title: Exp. Neurol.
– volume: 427
  start-page: 1495
  year: 2015
  end-page: 1512
  article-title: Transport of ‐glutamine, ‐alanine, ‐arginine and ‐histidine by the neuron‐specific in CNS
  publication-title: J. Mol. Biol.
– volume: 25
  start-page: 6221
  year: 2005
  end-page: 6234
  article-title: Presynaptic regulation of quantal size by the vesicular glutamate transporter VGLUT1
  publication-title: J. Neurosci.
– volume: 282
  start-page: 5152
  year: 2007
  end-page: 5159
  article-title: A critical role for system A amino acid transport in the regulation of dendritic development by brain‐derived neurotrophic factor (BDNF)
  publication-title: J. Biol. Chem.
– volume: 294
  start-page: 29
  year: 2000
  end-page: 32
  article-title: Neuroprotective effect of low dose riluzole in gerbil model of transient global ischemia
  publication-title: Neurosci. Lett.
– volume: 45
  start-page: 1055
  year: 1994
  end-page: 1060
  article-title: Block of the rat brain IIA sodium channel alpha subunit by the neuroprotective drug riluzole
  publication-title: Mol. Pharmacol.
– volume: 12
  start-page: 332
  year: 2007
  end-page: 343
  article-title: Glutamine in the central nervous system: function and dysfunction
  publication-title: Front Biosci.
– volume: 34
  start-page: 571
  year: 2013
  end-page: 585
  article-title: Evolutionary origin of amino acid transporter families , and and physiological, pathological and therapeutic aspects
  publication-title: Mol. Aspects Med.
– volume: 269
  start-page: 1730
  year: 1995
  end-page: 1734
  article-title: Regulation of hippocampal transmitter release during development and long‐term potentiation
  publication-title: Science
– volume: 76
  start-page: 1712
  year: 2001
  end-page: 1723
  article-title: Nitrogen shuttling between neurons and glial cells during glutamate synthesis
  publication-title: J. Neurochem.
– volume: 1371
  start-page: 180
  year: 2011
  end-page: 191
  article-title: Chronic electrographic seizure reduces glutamine and elevates glutamate in the extracellular fluid of rat brain
  publication-title: Brain Res.
– volume: 22
  start-page: 296
  year: 2016
  end-page: 305
  article-title: Age and Alzheimer's disease gene expression profiles reversed by the glutamate modulator riluzole
  publication-title: Mol. Psychiatry
– volume: 5
  start-page: 2145
  year: 1980
  end-page: 2150
  article-title: Comparative study of the release of glutamate and GABA, newly synthesized from glutamine, in various regions of the central nervous system
  publication-title: Neuroscience
– volume: 282
  start-page: 707
  year: 1997
  end-page: 714
  article-title: Differential action of riluzole on tetrodotoxin‐sensitive and tetrodotoxin‐resistant sodium channels
  publication-title: J. Pharmacol. Exp. Ther.
– volume: 288
  start-page: 1340
  year: 1999
  end-page: 1348
  article-title: Effect of riluzole on the neurological and neuropathological changes in an animal model of cardiac arrest‐induced movement disorder
  publication-title: J. Pharmacol. Exp. Ther.
– volume: 34
  start-page: 263
  year: 2016
  end-page: 272
  article-title: Glutamate neurotransmission in rodent models of traumatic brain injury
  publication-title: J. Neurotrauma
– volume: 14
  start-page: 7
  year: 2013
  end-page: 23
  article-title: Neurotrophin regulation of neural circuit development and function
  publication-title: Nat. Rev. Neurosci.
– volume: 26
  start-page: 671
  year: 2000
  end-page: 682
  article-title: Selective depression of low‐release probablity excitatory synapses by sodium channel blockers
  publication-title: Neuron
– volume: 284
  start-page: 8439
  year: 2009
  end-page: 8448
  article-title: Synaptic vesicle protein NTT4/XT1 ( ) catalyzes Na ‐coupled neutral amino acid transport
  publication-title: J. Biol. Chem.
– volume: 277
  start-page: 22966
  year: 2002
  end-page: 22973
  article-title: Functional characterization of two novel mammalian electrogenic proton‐dependent amino acid cotransporters
  publication-title: J. Biol. Chem.
– volume: 29
  start-page: 317
  year: 2013
  end-page: 323
  article-title: Do sodium channel blockers have neuroprotective effect after onset of ischemic insult?
  publication-title: Neurol. Res.
– volume: 168
  start-page: 531
  year: 1979
  end-page: 541
  article-title: Glutamate as a CNS transmitter. II. Regulation of synthesis in the releasable pool
  publication-title: Brain Res.
– volume: 4
  start-page: 1
  year: 2013
  end-page: 16
  article-title: The glutamate‐glutamine (GABA) cycle: importance of late postnatal development and potential reciprocal interactions between biosynthesis and degradation
  publication-title: Front. Endocrinol.
– volume: 51
  start-page: 39
  year: 1997
  end-page: 87
  article-title: Altered glutamatergic transmission in neurological disorders: from high extracellular glutamate to excessive synaptic efficacy
  publication-title: Prog. Neurobiol.
– volume: 32
  start-page: 1239
  year: 2010
  end-page: 1244
  article-title: Acivity‐dependent dendritic secretion of brain‐derived neurotrophic factor modulates synaptic plasticity
  publication-title: Eur. J. Neurosci.
– volume: 70
  start-page: 43
  year: 1990
  end-page: 77
  article-title: Role of amino acid transport and countertransport in nutrition and metabolism
  publication-title: Physiol. Rev.
– volume: 140
  start-page: 225
  year: 1992
  end-page: 230
  article-title: Neuroprotective actions of riluzole in rodent models of global and focal cerebral ischaemia
  publication-title: Neurosci. Lett.
– volume: 98
  start-page: 7206
  year: 2001
  end-page: 7211
  article-title: Identification and characterization of a lysosomal transporter for small neutral amino acids
  publication-title: Proc. Natl Acad. Sci.
– ident: e_1_2_8_9_1
  doi: 10.1523/JNEUROSCI.1466-13.2013
– ident: e_1_2_8_36_1
  doi: 10.1523/JNEUROSCI.20-04-01342.2000
– ident: e_1_2_8_55_1
  doi: 10.1007/s00424-003-1117-9
– ident: e_1_2_8_50_1
  doi: 10.1111/j.1460-9568.2010.07378.x
– ident: e_1_2_8_58_1
  doi: 10.1016/j.ejmech.2016.11.053
– ident: e_1_2_8_14_1
  doi: 10.1002/jnr.490350513
– ident: e_1_2_8_89_1
  doi: 10.1074/jbc.M806407200
– ident: e_1_2_8_65_1
  doi: 10.1038/nrn3379
– ident: e_1_2_8_72_1
  doi: 10.1111/j.1460-9568.2007.05967.x
– ident: e_1_2_8_32_1
  doi: 10.1074/jbc.M806470200
– ident: e_1_2_8_28_1
  doi: 10.1016/S0079-6123(07)63041-6
– ident: e_1_2_8_79_1
  doi: 10.1006/exnr.1997.6554
– ident: e_1_2_8_2_1
  doi: 10.2741/2067
– ident: e_1_2_8_27_1
  doi: 10.1089/neu.2015.4373
– ident: e_1_2_8_54_1
  doi: 10.1101/lm.54603
– ident: e_1_2_8_13_1
  doi: 10.1126/science.7569903
– ident: e_1_2_8_33_1
  doi: 10.1074/jbc.M110.162404
– ident: e_1_2_8_81_1
  doi: 10.1016/0006-8993(89)90045-0
– ident: e_1_2_8_86_1
  doi: 10.1016/j.neuroscience.2004.01.019
– ident: e_1_2_8_17_1
  doi: 10.1083/jcb.200201070
– volume-title: Functional identification of an activity‐induced, Ca2+ ‐dependent glutamine transporter in hippocampal neurons
  year: 2016
  ident: e_1_2_8_29_1
  contributor:
    fullname: Erickson J. D.
– ident: e_1_2_8_45_1
  doi: 10.1016/j.brainres.2010.11.064
– ident: e_1_2_8_51_1
  doi: 10.1007/978-3-319-45096-4_8
– ident: e_1_2_8_48_1
  doi: 10.1007/s10072-011-0828-5
– ident: e_1_2_8_68_1
  doi: 10.1016/0304-3940(92)90108-J
– ident: e_1_2_8_40_1
  doi: 10.1212/WNL.59.9_suppl_5.S3
– ident: e_1_2_8_67_1
  doi: 10.1016/S0896-6273(00)81203-9
– ident: e_1_2_8_59_1
  doi: 10.1016/0014-2999(93)90037-I
– ident: e_1_2_8_75_1
  doi: 10.1016/j.mam.2012.07.012
– ident: e_1_2_8_15_1
  doi: 10.1523/JNEUROSCI.23-23-08212.2003
– ident: e_1_2_8_31_1
  doi: 10.1111/j.1748-1716.2006.01552.x
– ident: e_1_2_8_71_1
  doi: 10.1016/0306-4522(80)90130-X
– ident: e_1_2_8_8_1
  doi: 10.1111/j.1471-4159.1984.tb05396.x
– ident: e_1_2_8_35_1
  doi: 10.1016/0006-8993(79)90307-X
– volume: 282
  start-page: 707
  year: 1997
  ident: e_1_2_8_77_1
  article-title: Differential action of riluzole on tetrodotoxin‐sensitive and tetrodotoxin‐resistant sodium channels
  publication-title: J. Pharmacol. Exp. Ther.
  contributor:
    fullname: Song J. H.
– ident: e_1_2_8_26_1
  doi: 10.1023/A:1015255312948
– ident: e_1_2_8_70_1
  doi: 10.1046/j.1471-4159.2003.01713.x
– ident: e_1_2_8_84_1
  doi: 10.1016/j.neuron.2013.12.026
– ident: e_1_2_8_66_1
  doi: 10.1038/mp.2016.33
– ident: e_1_2_8_53_1
  doi: 10.1016/S0304-3940(99)00810-1
– ident: e_1_2_8_18_1
  doi: 10.1016/0304-3940(92)90597-Z
– ident: e_1_2_8_62_1
  doi: 10.1042/bj2990321
– ident: e_1_2_8_4_1
  doi: 10.1179/016164107X159225
– ident: e_1_2_8_6_1
  doi: 10.1016/S0304-3940(00)01536-6
– ident: e_1_2_8_16_1
  doi: 10.1074/jbc.M608548200
– ident: e_1_2_8_44_1
  doi: 10.1523/JNEUROSCI.1198-07.2007
– ident: e_1_2_8_80_1
  doi: 10.1111/j.1527-3458.1997.tb00318.x
– ident: e_1_2_8_10_1
  doi: 10.1177/088307389701200802
– ident: e_1_2_8_20_1
  doi: 10.1152/physrev.1990.70.1.43
– ident: e_1_2_8_25_1
  doi: 10.1212/WNL.47.6_Suppl_4.233S
– ident: e_1_2_8_46_1
  doi: 10.1016/j.eplepsyres.2013.08.007
– ident: e_1_2_8_11_1
  doi: 10.1016/j.neuroscience.2009.09.015
– ident: e_1_2_8_73_1
  doi: 10.1097/00001756-200507130-00011
– volume: 25
  start-page: 7121
  year: 2005
  ident: e_1_2_8_23_1
  article-title: Homeostatic scaling of vesicular glutamate and GABA transporter expression in rat neocortical circuits
  publication-title: J. Neurosci.
  doi: 10.1523/JNEUROSCI.5221-04.2005
  contributor:
    fullname: Gois S.
– ident: e_1_2_8_7_1
  doi: 10.1007/BF00370302
– ident: e_1_2_8_21_1
  doi: 10.1007/s13311-014-0305-y
– ident: e_1_2_8_19_1
  doi: 10.1038/sj.jcbfm.9600490
– ident: e_1_2_8_76_1
  doi: 10.1046/j.1471-4159.2001.00074.x
– ident: e_1_2_8_88_1
  doi: 10.1523/JNEUROSCI.3003-04.2005
– ident: e_1_2_8_57_1
  doi: 10.1523/JNEUROSCI.09-11-03720.1989
– ident: e_1_2_8_43_1
  doi: 10.1093/cercor/bhn151
– ident: e_1_2_8_30_1
  doi: 10.1523/JNEUROSCI.23-30-09697.2003
– volume: 45
  start-page: 1055
  year: 1994
  ident: e_1_2_8_37_1
  article-title: Block of the rat brain IIA sodium channel alpha subunit by the neuroprotective drug riluzole
  publication-title: Mol. Pharmacol.
  contributor:
    fullname: Herbert T.
– ident: e_1_2_8_74_1
  doi: 10.1073/pnas.121183498
– ident: e_1_2_8_61_1
  doi: 10.1046/j.1460-9568.1999.00540.x
– ident: e_1_2_8_52_1
  doi: 10.1046/j.1471-4159.2001.00156.x
– ident: e_1_2_8_63_1
  doi: 10.1016/j.biopha.2016.12.067
– ident: e_1_2_8_34_1
  doi: 10.1016/j.jmb.2014.10.016
– ident: e_1_2_8_78_1
  doi: 10.1097/00001756-200207020-00019
– ident: e_1_2_8_85_1
  doi: 10.1021/acsami.6b01776
– ident: e_1_2_8_49_1
  doi: 10.1007/PL00005241
– ident: e_1_2_8_56_1
  doi: 10.1074/jbc.M212718200
– volume: 288
  start-page: 1340
  year: 1999
  ident: e_1_2_8_47_1
  article-title: Effect of riluzole on the neurological and neuropathological changes in an animal model of cardiac arrest‐induced movement disorder
  publication-title: J. Pharmacol. Exp. Ther.
  contributor:
    fullname: Kanthasamy A. G.
– ident: e_1_2_8_60_1
  doi: 10.1002/jnr.23561
– ident: e_1_2_8_12_1
  doi: 10.1074/jbc.M200374200
– ident: e_1_2_8_39_1
  doi: 10.1016/j.neuroscience.2005.08.083
– ident: e_1_2_8_41_1
  doi: 10.1016/j.neuron.2009.06.010
– ident: e_1_2_8_64_1
  doi: 10.1016/S0301-0082(96)00049-4
– ident: e_1_2_8_69_1
  doi: 10.1097/00001756-199806220-00037
– ident: e_1_2_8_22_1
  doi: 10.1016/j.neuint.2005.11.016
– ident: e_1_2_8_87_1
  doi: 10.1152/jn.00464.2004
– ident: e_1_2_8_42_1
  doi: 10.1111/jnc.13230
– ident: e_1_2_8_82_1
  doi: 10.1111/j.1471-4159.2012.07684.x
– ident: e_1_2_8_3_1
  doi: 10.1074/jbc.M110942200
– ident: e_1_2_8_38_1
  doi: 10.3389/fendo.2013.00059
– ident: e_1_2_8_83_1
  doi: 10.1523/JNEUROSCI.0106-09.2010
– ident: e_1_2_8_5_1
  doi: 10.1152/jn.00665.2001
– volume: 23
  start-page: 1563
  year: 2003
  ident: e_1_2_8_24_1
  article-title: Plasma membrane GABA transporters reside on distinct vesicles and undergo rapid regulated recycling
  publication-title: J. Neurosci.
  doi: 10.1523/JNEUROSCI.23-05-01563.2003
  contributor:
    fullname: Deken S. L.
SSID ssj0016461
Score 2.3844976
Snippet Glutamine (Gln) is considered the preferred precursor for the neurotransmitter pool of glutamate (Glu), the major excitatory transmitter in the mammalian CNS....
Abstract Glutamine (Gln) is considered the preferred precursor for the neurotransmitter pool of glutamate (Glu), the major excitatory transmitter in the...
SourceID pubmedcentral
proquest
crossref
pubmed
wiley
SourceType Open Access Repository
Aggregation Database
Index Database
Publisher
StartPage 29
SubjectTerms activity‐dependent regulation
Affinity
Amino Acid Transport System X-AG - drug effects
Amino acids
Animals
Astrocytes
Astrocytes - drug effects
Astrocytes - metabolism
Axonal transport
beta-Alanine - analogs & derivatives
beta-Alanine - metabolism
Calcium
Calcium (extracellular)
Calcium - metabolism
Calcium Channel Blockers - pharmacology
Calcium channels
Calcium channels (voltage-gated)
Calcium transport
Central nervous system
Channels
Circuits
Competition
Displays
Enrichment
Excitatory Amino Acid Antagonists - pharmacology
Excitotoxicity
Female
Functional anatomy
glutamate/glutamine cycle
Glutamatergic transmission
Glutamic acid
Glutamine
Glutamine - metabolism
Hippocampus
Hippocampus - cytology
Hippocampus - drug effects
Hippocampus - metabolism
In vitro methods and tests
Inhibition
Inhibitors
Ions
Low concentrations
Mammals
Maturation
Nervous system
Neural networks
neuronal glutamine transporter
Neurons
Neurons - drug effects
Neurons - metabolism
neuroprotection
Neuroprotective Agents - pharmacology
Neurosciences
neurotransmitter cycling
Physiology
Potassium - pharmacology
Pregnancy
Rats
Rats, Sprague-Dawley
Riluzole - pharmacology
Sodium channels (voltage-gated)
Tetrodotoxin
Transport
γ-Aminobutyric acid
Title Functional identification of activity‐regulated, high‐affinity glutamine transport in hippocampal neurons inhibited by riluzole
URI https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fjnc.14046
https://www.ncbi.nlm.nih.gov/pubmed/28423185
https://www.proquest.com/docview/1911516892
https://search.proquest.com/docview/1891089828
https://pubmed.ncbi.nlm.nih.gov/PMC5594568
Volume 142
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1La9wwEB5CLu2lTZM-3KRBLaX0UIesLckyPYWlSwg0h9JADgUjyVJjuvEu-zhsToH8gf7G_pLOyA-yCYHSm7HHtizN4xt59AngvXSpV5L7WGtlY26zNM5zk8VCZ7nR7lCVhqYGvp7K4zN-ci7ON-Bztxam4YfoJ9zIMoK_JgPXZn7byNF-iBuG6LaJSI8A0beeOoposwY9UzhqZssqFKp4ujvXY9E9gHm_TvI2fg0BaPQUfnRNb-pOfh0sF-bAXt1hdfzPb9uCJy0wZUeNJj2DDVdvw85RjUn55Yp9YKFUNMzBb8OjYbdN3A7cjDAyNhOKrCrb2qMw3GziGS2boN0p_lz_njW73rvyEyOOZDyjva_Qo6zYT1R_fYmtZouOa51VNYpNpxhq0WGNWeDdrOd4-qIyBJOZWbFZNV5eTcbuOZyNvnwfHsftzg6x5TyVsRfGEhWhcCk6XO5L9CK5Mtoantgk0S5LtOBaKIcSEjMiaZVxQshSe-2dTl_AZj2p3StgYqAPrbA5qpzhIucmKzOBGjgYSF-mUkTwrhvjYtoQeBR94lPbInRzBHvd6BetDc8LzGQRDkmVJxG87S9j79IvFV27yRJlFMItlWPaGsHLRln6t2DgT2htegTZmhr1AsTsvX6lri4CwzemeQhs8Zkfg5Y83PDi5HQYDl7_u-guPE4Im4Sa4z3YXMyW7g0iq4XZDya0T9FN_AUf5icS
link.rule.ids 230,315,786,790,891,1382,27955,27956,46327,46751
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB6VcigXHi2PlAIGIcSBVN3EdhyJS7WwWkq7B9RKvaDIdmwadetdbXcP2xMSf4DfyC9h7DzUpUJC3KJkknjjeXwzO_4M8Jqb1ApObSyl0DHVWRrnucpiJrNcSbMnSuVLA0cjPjyhB6fsdA3et2than6IruDmLSP4a2_gviB93crRgDw5DL8Ft9HcmTfLD1868ihPnNXruMJRNxteodDH0966Go1uQMybnZLXEWwIQYN78LUdfN15cr67mKtdffUHr-P__rr7cLfBpmS_VqYHsGbcJmztO8zLL5bkDQndoqEMvwkb_XanuC34McDgWNcUSVU27UdhxsnEEr9ywm9Q8ev7z1m98b0p3xFPk4xnpLUVOpUl-YYWIC9w2GTe0q2TyqHYdIrRFn3WmATqTXeJp88q5ZEyUUsyq8aLq8nYPISTwcfj_jBuNneINaUpjy1T2rMRMpOiz6W2REeSCyW1oolOEmmyRDIqmTAowTEp4loowxgvpZXWyPQRrLuJM0-AsJ7c00znqHWKspyqrMwYKmGvx22ZchbBq3aSi2nN4VF0uY_TRfjMEey00180ZnxZYDKLiIiLPIngZXcZv67_V0U6M1mgjEDEJXLMXCN4XGtL9xaM_Ylfnh5BtqJHnYAn91694qqzQPKNmR5iW3zm26Amfx94cTDqh4Ptfxd9ARvD46PD4vDT6PNTuJN4qBJakHdgfT5bmGcItObqebCn33TYKkw
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB6VIgEXHi2PQAGDEOLQVN3Edhz1VG1ZlQIrhKjUA1JkOzaN2HpX293D9oTEH-hv7C_p2HmoS4WEuEXJJHHseXzjjD8DvOEmtYJTG0spdEx1lsZ5rrKYySxX0myLUvmpgc9Dvn9ID47Y0QrstGthan6IbsLNW0bw197AJ6W9auRoP54bht-Am5Snic-89r523FGeN6vXUYWjaja0QqGMp711ORhdQ5jXCyWvAtgQgQb34Hvb9rrw5OfWfKa29NkftI7_-XH34W6DTMlurUoPYMW4NVjfdZiVnyzIWxJqRcMk_Brc7rf7xK3D7wGGxnpGkVRlU3wUxpuMLfHrJvz2FBe_zqf1tvem3CSeJBnPSGsrdCkL8gP1X55gq8msJVsnlUOxyQRjLXqsEQnEm-4UTx9XyuNkohZkWo3mZ-OReQiHg_ff-vtxs7VDrClNeWyZ0p6LkJkUPS61JbqRXCipFU10kkiTJZJRyYRBCY4pEddCGcZ4Ka20RqaPYNWNnXkChPXktmY6R51TlOVUZWXGUAV7PW7LlLMIXrdjXExqBo-iy3ycLkI3R7DRjn7RGPFpgaks4iEu8iSCV91l7F3_T0U6M56jjEC8JXLMWyN4XCtL9xaM_IlfnB5BtqRGnYCn9l6-4qrjQPGNeR4iW3zmu6Alf294cTDsh4On_y76Em592RsUnz4MPz6DO4nHKaH-eANWZ9O5eY4oa6ZeBGu6BO1UKPs
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Functional+identification+of+activity%E2%80%90regulated%2C+high%E2%80%90affinity+glutamine+transport+in+hippocampal+neurons+inhibited+by+riluzole&rft.jtitle=Journal+of+neurochemistry&rft.au=Erickson%2C+Jeffrey+D.&rft.date=2017-07-01&rft.issn=0022-3042&rft.eissn=1471-4159&rft.volume=142&rft.issue=1&rft.spage=29&rft.epage=40&rft_id=info:doi/10.1111%2Fjnc.14046&rft.externalDBID=n%2Fa&rft.externalDocID=10_1111_jnc_14046
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0022-3042&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0022-3042&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0022-3042&client=summon